| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,027,344.48 | 2,816,688.29 | 2,710,981.11 | 2,539,995 | 2,010,798.39 |
| Cost of Revenue
|
-2,837,308.63 | -2,628,458.04 | -2,528,626.65 | -2,369,150.10 | -1,883,078.82 |
|
Gross Profit
|
190,035.86 | 188,230.25 | 182,354.46 | 170,844.90 | 127,719.57 |
|
Selling, General and Administrative Expenses
|
-168,603.39 | -165,839.58 | -154,878.76 | -137,301.67 | -101,474.36 |
| Depreciation, Amortization and Depletion
|
-9,862 | -9,835.20 | -9,495.18 | -7,576.65 | -3,643.84 |
|
Operating Income/Expenses
|
-178,465.40 | -175,674.78 | -164,373.94 | -144,878.31 | -105,118.20 |
|
Total Operating Profit/Loss
|
11,570.46 | 12,555.47 | 17,980.51 | 25,966.58 | 22,601.37 |
| Total Net Finance Income/Expense
|
-10,140.19 | -10,443.57 | -10,413.23 | -8,550.43 | -2,249.55 |
| Irregular Income/Expenses
|
1,796.72 | -- | -- | -- | -- |
|
Other Income/Expense, Non-Operating
|
-353.21 | -548.16 | -104.80 | -113.76 | 1,123.69 |
|
Non-Operating Income/Expenses, Total
|
-8,696.68 | -10,991.73 | -10,518.03 | -8,664.19 | -1,125.86 |
|
Pretax Income
|
2,873.78 | 1,563.74 | 7,462.49 | 17,302.39 | 21,475.50 |
|
Provision for Income Tax
|
-1,077 | -995 | -3,126 | -5,706 | -6,473.38 |
|
Earnings from Equity Interest, Post-Tax
|
-- | -- | -- | 0 | 1,670.13 |
|
Net Income from Continuing Operations
|
1,796.78 | 568.74 | 4,336.49 | 11,596.39 | 16,672.26 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,796.78 | 568.74 | 4,336.49 | 11,596.39 | 16,672.26 |
|
Net Income after Non-Controlling/Minority Interests
|
1,796.78 | 568.74 | 4,336.49 | 11,596.39 | 16,672.26 |
|
Net Income Available to Common Stockholders
|
1,796.78 | 568.74 | 4,336.49 | 11,596.39 | 16,672.26 |
|
Diluted Net Income Available to Common Stockholders
|
1,796.78 | 568.74 | 4,336.49 | 11,596.39 | 16,672.26 |
|
Common Dividend per Share
|
0.67 | 0.67 | 0.67 | 3.81 | 3.81 |
| Basic EPS
|
1.95 | 0.62 | 4.83 | 13.23 | 19.58 |
| Diluted EPS
|
1.93 | 0.61 | 4.77 | 12.97 | 19.06 |
|
Basic Weighted Average Shares Outstanding
|
925.77 | 919.78 | 898.53 | 876.22 | 851.55 |
|
Diluted Weighted Average Shares Outstanding
|
932.59 | 924.73 | 910.17 | 893.78 | 874.59 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
13,013.97 | 12,007.31 | 17,875.72 | 25,852.82 | 23,725.06 |
|
EBITDA
|
22,875.98 | 21,842.51 | 27,370.90 | 33,429.47 | 27,368.90 |
|
Normalized EBITDA
|
23,364 | 24,303.72 | 29,683.21 | 36,013.18 | 30,332.08 |
|
Normalized Income
|
2,101.91 | 2,513.09 | 6,163.22 | 13,328.05 | 18,742.24 |
|
Total Unusual Items
|
488.02 | 2,461.21 | 2,312.31 | 2,583.71 | 2,963.18 |
9/30/2022 - 8/4/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade